Analytical Data
-
Gene name
CPP
- Application
-
Alternative Names
CPP；CPP32；Caspase-3
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q01957
-
Expression Region
1-315aa
-
AA Sequence
MFTFILMFYIGYGIDFNTWVANNNKHFTAVESLRRRAIFNMNARIVAENNRKETFKLSVDGPFAAMTNEEYNSLLKLKRSGEEKGEVRYLNIQAPKAVDWRKKGKVTPIRDQGNCGSCYTFGSIAALEGRLLIEKGGDSETLDLSEEHMVQCTREDGNNGCNGGLGSNVYNYIMENGIAKESDYPYTGSDSTCRSDVKAFAKIKSYNRVARNNEVELKAAISQGLVDVSIDASSVQFQLYKSGAYTDKQCKNNYFALNHEVCAVGYGVVDGKECWIVRNSWGTGWGEKGYINMVIEGNTCGVATDPLYPTGVEYL
-
Molecular Weight
35 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on CPP (Cell-Penetrating Peptides) recombinant proteins has gained significant attention in recent years due to their potential to facilitate the delivery of a variety of therapeutic agents, including peptides, proteins, and nucleic acids, across biological membranes. CPPs are short sequences of amino acids that can penetrate cell membranes, enabling the transport of cargo molecules directly into cells without the need for invasive techniques. The growing interest in CPPs is driven by the increasing demand for innovative drug delivery systems that can enhance the efficacy of treatments while reducing side effects. Advances in molecular biology and protein engineering have enabled researchers to develop CPPs with improved specificity, efficiency, and stability. Additionally, the ability to fuse CPPs with recombinant proteins allows for targeted delivery, thereby enhancing therapeutic outcomes for diseases such as cancer, genetic disorders, and viral infections. As a result, CPPs have emerged as a promising tool in the fields of biotechnology and medicine, paving the way for novel approaches to drug development and therapeutic intervention. Ongoing studies are focused on elucidating the mechanisms underlying CPP-mediated cellular uptake, optimizing their design for specific applications, and exploring their potential in various medical fields, making CPPs a vibrant area of investigation in contemporary biomedical research.
